MYGN icon

Myriad Genetics

187 hedge funds and large institutions have $1.49B invested in Myriad Genetics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 59 increasing their positions, 66 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

11% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 66

15% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 27

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
187
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.39M
Puts
$2.95M
Net Calls
Net Calls Change

Top Buyers

1 +$35.3M
2 +$28.3M
3 +$18.3M
4
Goldman Sachs
Goldman Sachs
New York
+$10.3M
5
Bank of America
Bank of America
North Carolina
+$9.73M

Top Sellers

1 -$14.1M
2 -$13.4M
3 -$12.3M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$10.2M
5
Two Sigma Investments
Two Sigma Investments
New York
-$7.28M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$2.23M
52
$2.15M
53
$2.03M
54
$1.94M
55
$1.93M
56
$1.93M
57
$1.85M
58
$1.79M
59
$1.73M
60
$1.7M
61
$1.52M
62
$1.48M
63
$1.43M
64
$1.27M
65
$1.27M
66
$1.24M
67
$1.24M
68
$1.23M
69
$1.19M
70
$1.16M
71
$1.15M
72
$1.1M
73
$1.05M
74
$1M
75
$1M